Latest News about MRK
Recent news which mentions MRK
   McDonald's Revenues Expected To Increase, Plus Merck And More On CNBC's 'Final Trades'
   
  
  
  January 04, 2024
  From Benzinga
 
   2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
   
  
  
  January 04, 2024
  From Benzinga
 From Benzinga
 
   Revenge of the Boring Stocks! Dividends Are Sexy Again.
   
  
  
  January 03, 2024
  From InvestorPlace
 From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  January 02, 2024
  From Benzinga
 
   There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
   
  
  
  December 29, 2023
  From Motley Fool
 
   Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?
   
  
  
  December 29, 2023
  From Motley Fool
 
   Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
   
  
  
  December 29, 2023
  From Benzinga
 
   Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
   
  
  
  December 28, 2023
  From Benzinga
 
   January Effect: 3 Under-the-Radar Stocks Poised for a New Year Jump
   
  
  
  December 24, 2023
  From InvestorPlace
 
   7 Small-Cap Stocks That Wall Street Loves for Good Reason
   
  
  
  December 22, 2023
  From InvestorPlace
 
   7 Best Dow Jones Stocks to Buy for Conservative Investors
   
  
  
  December 21, 2023
  From InvestorPlace
 From Benzinga
 
   Better Dividend Stock: Bristol Myers Squibb or Merck?
   
  
  
  December 19, 2023
  From Motley Fool
 
   Jim Cramer Slams FTC Chair Lina Khan's Policies For Hampering Investor Returns: 'One-Woman Wrecking Crew For Your Stock Portfolio'
   
  
  
  December 18, 2023
  From Benzinga
 From Motley Fool
 From Motley Fool
 
   Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
   
  
  
  December 16, 2023
  From Benzinga
 
   What's Going On With C4 Therapeutics Stock?
   
  
  
  December 15, 2023
  From Benzinga
 
   FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
   
  
  
  December 15, 2023
  From Benzinga
 
   MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer
   
  
  
  December 14, 2023
  From InvestorPlace
 
   Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
   
  
  
  December 14, 2023
  From Benzinga
 
   Moderna’s stock boosted by positive data from trial of melanoma treatment combined with Merck’s Keytruda
   
  
  
  December 14, 2023
  From MarketWatch
 
   Why Is Moderna (MRNA) Stock Up 11% Today?
   
  
  
  December 14, 2023
  From InvestorPlace
 
   Moderna Stock Is Soaring Today - Here's Why
   
  
  
  December 14, 2023
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
